Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

BD FAS:FC Chimeric Fusion Cell Surface Protein

Catalog No. BDB556578 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB556578 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB556578 Supplier BD Supplier No. 556578

Item Discontinued This item has been discontinued by the supplier. Please to view product availability in your area.

Mediates apoptosis when cross-linked with agonistic anti-Fas antibodies or Fas ligand

  • Comprises of extracellular domain of Fas receptor fused to Fc portion of human IgG1
  • Produced in Baculovirus Expression Vector System (BEVS)
  • Prified by affinity chromatography
  • olecular weight of 50 kDa
  • Fas belongs to TNF (tumor necrosis factor)/NGF (nerve growth factor) receptor family
  • Expressed in various tissues and cells
  • FasL belongs to TNF cytokine family
  • FasL exists as membrane-bound or soluble form and and is expressed by activated T and NK cells

Avoid multiple freeze-thaw cycles to prevent protein degradation.

Immunoprecipitation, neutralization, flow cytometry.

TRUSTED_SUSTAINABILITY

Specifications

Quantity 100 μg
Storage Buffer Aqueous Buffered solution containing no preservative; sterile filtered
Content And Storage -80°C
For Use With (Application) Flow Cytometry, Immunoprecipitation, Neutralization

Research-use-only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.